740 related articles for article (PubMed ID: 19338486)
1. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
4. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
[TBL] [Abstract][Full Text] [Related]
5. Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
Sini M; Sorbello O; Sanna F; Battolu F; Civolani A; Fanni D; Faa G; Demelia L
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):111-7. PubMed ID: 23011036
[TBL] [Abstract][Full Text] [Related]
6. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
8. Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
Huang L; Yu X; Zhang J; Liu X; Zhang Y; Jiao X; Yu X
Biol Trace Elem Res; 2012 May; 146(2):154-9. PubMed ID: 22076732
[TBL] [Abstract][Full Text] [Related]
9. Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Cope-Yokoyama S; Finegold MJ; Sturniolo GC; Kim K; Mescoli C; Rugge M; Medici V
World J Gastroenterol; 2010 Mar; 16(12):1487-94. PubMed ID: 20333789
[TBL] [Abstract][Full Text] [Related]
10. Wilson disease in children: analysis of 57 cases.
Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
[TBL] [Abstract][Full Text] [Related]
11. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
12. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Medici V; Rossaro L; Sturniolo GC
Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
[TBL] [Abstract][Full Text] [Related]
14. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
[TBL] [Abstract][Full Text] [Related]
15. Wilson disease as a cause of liver injury in cystic fibrosis.
Kotalová R; Jirsa M; Vávrová V; Vrábelová-Pouchlá S; Macek M
J Cyst Fibros; 2009 Jan; 8(1):63-5. PubMed ID: 18948065
[TBL] [Abstract][Full Text] [Related]
16. [Clinical character and therapeutic effect of late-onset Wilson disease].
Zhang Y; Yang X; Tang X; Luo H; Lei J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):40-4. PubMed ID: 19197125
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
18. [Nephrolithiasis as an initial clinical manifestation of Wilson-Konovalov disease].
Rakhimova OIu; Rozina TP; Ignatova TM
Ter Arkh; 2003; 75(6):60-2. PubMed ID: 12920963
[No Abstract] [Full Text] [Related]
19. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
20. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
